New drug cocktail targets Hard-to-Treat cancers

NCT ID NCT07268040

First seen Dec 08, 2025 · Last updated May 15, 2026 · Updated 23 times

Summary

This study tests a new drug called SHR-7787 combined with other cancer treatments in people with advanced solid tumors that cannot be removed by surgery. The goal is to find safe doses and see if the combination shrinks tumors or slows cancer growth. About 400 adults with various solid tumors will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai Pulmonary Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200433, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology

    RECRUITING

    Wuhan, Hubei, 430030, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.